Results
eNauka >
Rezultati >
BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study
| Naziv: | BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study | Autori  : | Weichenthal, Michael; ...; Popovic, Aleksandar; ...; (broj, koautora 31) | Godina: | 2026 | Publikacija: | EJC SKIN CANCER | ISSN: | 2772-6118  Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 4 str. 100776-100776 | DOI: | 10.1016/j.ejcskn.2026.100776 | WoS-ID: | 001791987500004 | Scopus-ID: | 2-s2.0-105027644904 | URI: | https://enauka.gov.rs/handle/123456789/1046553 | Projekat: | Novartis AG, Basel, Switzerland | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.